NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totaling 22,408 shares, a decrease of 52.3% from the March 31st total of 46,988 shares. Approximately 13.3% of the shares of the company are short sold. Based on an average trading volume of 16,760 shares, the short-interest ratio is currently 1.3 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

NewGenIvf Group Price Performance

NASDAQ:NIVF remained flat at $1.96 during mid-day trading on Monday. 15,117 shares of the company traded hands, compared to its average volume of 151,879. The firm’s 50-day moving average is $2.35 and its 200-day moving average is $17.89. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 12 month low of $1.52 and a 12 month high of $1,839.00.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.